Merck Serono

Companies Merck Serono

News Merck Serono

• Frost & Sullivan commends Merck Serono for its excellence in product differentiation

  Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool.click®2 – more

• Sixth Merck Serono spin-off company to focus on gastrointestinal immunological disorders

  Merck Serono announced the creation of Calypso Biotech, the sixth spin-off company resulting from its Entrepreneur Partnership Program (EPP). Calypso Biotech was formed around Merck Serono’s R&D portfolio in the field of inflammatory bowel diseases, targeting selected niche indications with high unm more

• Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop mGluR4 PAMs for Parkinson’s disease

  Domain Therapeutics S.A. announced that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson’s disease. This agreement between Domain Therapeutics and Prexto more

Publications Merck Serono

• Cash injection set to revive Swiss drug site

  Cash injection set to revive Swiss drug site Nature 492, 7428 (2012). http://www.nature.com/doifinder/10.1038/492168a Author: Daniel Cressey Merck Serono facility could become biotech research hub. more

• Swiss hope for phoenix from Merck Serono's ashes

  Swiss hope for phoenix from Merck Serono's ashes Nature Biotechnology 30, 569 (2012). doi:10.1038/nbt0712-569 Author: Nuala Moran more

Market studies Merck Serono

• Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development

  GBI Research, leading business intelligence provider, has released its latest research report, entitled “Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development". Over the last decade, protein and peptide-based therapeutics have attracted more and more attention in the phar more

• Israel Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: Israel’s innovative pharmaceutical industry continues to emerge from its strong generic drugs heritage. While most multinationals do not have a direct discovery or manufacturing presence, we expect an increasing number to look to enter through tie-ups and acquisitions of innovative local more

• The Medical House PLC - Strategic SWOT Analysis Review

  The Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its products include ASI, a single-use, disposable autoinjector; and Needle-free Jet Injectors, which utilize spring power to inject liquid drugs without a needle. In addition, t more

Websites Merck Serono